Mantle Cell Lymphoma Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: MC26F908DDD3EN
Market Monitor Global

Abstracts

Mantle cell lymphoma (MCL) is a heterogeneous aggressive disease and remains incurable with current chemotherapies. The development of monoclonal antibody (mAb) has led to substantial achievement in immunotherapeutic strategies for B-cell lymphomas including MCL.

This report contains market size and forecasts of Mantle Cell Lymphoma Therapeutics in Global, including the following market information:

Global Mantle Cell Lymphoma Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Mantle Cell Lymphoma Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Combination Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Mantle Cell Lymphoma Therapeutics include Allergan Plc, AstraZeneca Plc, Celgene Corp., Johnson & Johnson Services Inc. and Takeda Pharmaceutical Co. Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mantle Cell Lymphoma Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Mantle Cell Lymphoma Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Mantle Cell Lymphoma Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Combination Therapy
• Monotherapy

Global Mantle Cell Lymphoma Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Mantle Cell Lymphoma Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Research Institute
• Other

Global Mantle Cell Lymphoma Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Mantle Cell Lymphoma Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Mantle Cell Lymphoma Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Mantle Cell Lymphoma Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan Plc
• AstraZeneca Plc
• Celgene Corp.
• Johnson & Johnson Services Inc.
• Takeda Pharmaceutical Co. Ltd.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Mantle Cell Lymphoma Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Mantle Cell Lymphoma Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MANTLE CELL LYMPHOMA THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Mantle Cell Lymphoma Therapeutics Market Size: 2021 VS 2028
2.2 Global Mantle Cell Lymphoma Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Mantle Cell Lymphoma Therapeutics Players in Global Market
3.2 Top Global Mantle Cell Lymphoma Therapeutics Companies Ranked by Revenue
3.3 Global Mantle Cell Lymphoma Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Mantle Cell Lymphoma Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Mantle Cell Lymphoma Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mantle Cell Lymphoma Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Mantle Cell Lymphoma Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Mantle Cell Lymphoma Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Mantle Cell Lymphoma Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Combination Therapy
  4.1.3 Monotherapy
4.2 By Type - Global Mantle Cell Lymphoma Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Mantle Cell Lymphoma Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Mantle Cell Lymphoma Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Mantle Cell Lymphoma Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Mantle Cell Lymphoma Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Research Institute
  5.1.4 Other
5.2 By Application - Global Mantle Cell Lymphoma Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Mantle Cell Lymphoma Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Mantle Cell Lymphoma Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Mantle Cell Lymphoma Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Mantle Cell Lymphoma Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Mantle Cell Lymphoma Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Mantle Cell Lymphoma Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Mantle Cell Lymphoma Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Mantle Cell Lymphoma Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Mantle Cell Lymphoma Therapeutics Revenue, 2017-2028
  6.3.2 US Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
  6.3.3 Canada Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Mantle Cell Lymphoma Therapeutics Revenue, 2017-2028
  6.4.2 Germany Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
  6.4.3 France Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
  6.4.5 Italy Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
  6.4.6 Russia Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Mantle Cell Lymphoma Therapeutics Revenue, 2017-2028
  6.5.2 China Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
  6.5.3 Japan Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
  6.5.6 India Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Mantle Cell Lymphoma Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Mantle Cell Lymphoma Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
  6.7.3 Israel Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028
  6.7.5 UAE Mantle Cell Lymphoma Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Allergan Plc
  7.1.1 Allergan Plc Corporate Summary
  7.1.2 Allergan Plc Business Overview
  7.1.3 Allergan Plc Mantle Cell Lymphoma Therapeutics Major Product Offerings
  7.1.4 Allergan Plc Mantle Cell Lymphoma Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Allergan Plc Key News
7.2 AstraZeneca Plc
  7.2.1 AstraZeneca Plc Corporate Summary
  7.2.2 AstraZeneca Plc Business Overview
  7.2.3 AstraZeneca Plc Mantle Cell Lymphoma Therapeutics Major Product Offerings
  7.2.4 AstraZeneca Plc Mantle Cell Lymphoma Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 AstraZeneca Plc Key News
7.3 Celgene Corp.
  7.3.1 Celgene Corp. Corporate Summary
  7.3.2 Celgene Corp. Business Overview
  7.3.3 Celgene Corp. Mantle Cell Lymphoma Therapeutics Major Product Offerings
  7.3.4 Celgene Corp. Mantle Cell Lymphoma Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Celgene Corp. Key News
7.4 Johnson & Johnson Services Inc.
  7.4.1 Johnson & Johnson Services Inc. Corporate Summary
  7.4.2 Johnson & Johnson Services Inc. Business Overview
  7.4.3 Johnson & Johnson Services Inc. Mantle Cell Lymphoma Therapeutics Major Product Offerings
  7.4.4 Johnson & Johnson Services Inc. Mantle Cell Lymphoma Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Services Inc. Key News
7.5 Takeda Pharmaceutical Co. Ltd.
  7.5.1 Takeda Pharmaceutical Co. Ltd. Corporate Summary
  7.5.2 Takeda Pharmaceutical Co. Ltd. Business Overview
  7.5.3 Takeda Pharmaceutical Co. Ltd. Mantle Cell Lymphoma Therapeutics Major Product Offerings
  7.5.4 Takeda Pharmaceutical Co. Ltd. Mantle Cell Lymphoma Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Takeda Pharmaceutical Co. Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Mantle Cell Lymphoma Therapeutics Market Opportunities & Trends in Global Market
Table 2. Mantle Cell Lymphoma Therapeutics Market Drivers in Global Market
Table 3. Mantle Cell Lymphoma Therapeutics Market Restraints in Global Market
Table 4. Key Players of Mantle Cell Lymphoma Therapeutics in Global Market
Table 5. Top Mantle Cell Lymphoma Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Mantle Cell Lymphoma Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Mantle Cell Lymphoma Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Mantle Cell Lymphoma Therapeutics Product Type
Table 9. List of Global Tier 1 Mantle Cell Lymphoma Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mantle Cell Lymphoma Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Mantle Cell Lymphoma Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Mantle Cell Lymphoma Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Mantle Cell Lymphoma Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Mantle Cell Lymphoma Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Mantle Cell Lymphoma Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Mantle Cell Lymphoma Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Allergan Plc Corporate Summary
Table 31. Allergan Plc Mantle Cell Lymphoma Therapeutics Product Offerings
Table 32. Allergan Plc Mantle Cell Lymphoma Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Plc Corporate Summary
Table 34. AstraZeneca Plc Mantle Cell Lymphoma Therapeutics Product Offerings
Table 35. AstraZeneca Plc Mantle Cell Lymphoma Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Celgene Corp. Corporate Summary
Table 37. Celgene Corp. Mantle Cell Lymphoma Therapeutics Product Offerings
Table 38. Celgene Corp. Mantle Cell Lymphoma Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Services Inc. Corporate Summary
Table 40. Johnson & Johnson Services Inc. Mantle Cell Lymphoma Therapeutics Product Offerings
Table 41. Johnson & Johnson Services Inc. Mantle Cell Lymphoma Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Takeda Pharmaceutical Co. Ltd. Corporate Summary
Table 43. Takeda Pharmaceutical Co. Ltd. Mantle Cell Lymphoma Therapeutics Product Offerings
Table 44. Takeda Pharmaceutical Co. Ltd. Mantle Cell Lymphoma Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Mantle Cell Lymphoma Therapeutics Segment by Type in 2021
Figure 2. Mantle Cell Lymphoma Therapeutics Segment by Application in 2021
Figure 3. Global Mantle Cell Lymphoma Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Mantle Cell Lymphoma Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Mantle Cell Lymphoma Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Mantle Cell Lymphoma Therapeutics Revenue in 2021
Figure 8. By Type - Global Mantle Cell Lymphoma Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Mantle Cell Lymphoma Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Mantle Cell Lymphoma Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Mantle Cell Lymphoma Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Mantle Cell Lymphoma Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Mantle Cell Lymphoma Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Mantle Cell Lymphoma Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Mantle Cell Lymphoma Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Mantle Cell Lymphoma Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Allergan Plc Mantle Cell Lymphoma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Plc Mantle Cell Lymphoma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Celgene Corp. Mantle Cell Lymphoma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Services Inc. Mantle Cell Lymphoma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Takeda Pharmaceutical Co. Ltd. Mantle Cell Lymphoma Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)